Explore Novo Nordisk's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.
| Metric | 2025 | 2024 | 2023 | 2022 and older |
|---|---|---|---|---|
Board Meeting Count | 19a | N/A | N/A | |
Board Meeting Attendance Rate | 99.56%b | N/A | N/A | |
Audit Committee Meetings | 5a | N/A | N/A | |
Audit Committee Meeting Attendance Rate | 100%b | N/A | N/A | |
Compensation/Remuneration Committee Meetings | 6a | N/A | N/A | |
Compensation/Remuneration Committee Meeting Attendance Rate | 100%b | N/A | N/A | |
Nomination Committee Meetings | 3a | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.